Hermetica Superfood Encyclopedia
The Short Answer
Calotropis procera contains betulin (58% of ethanolic extract), α-amyrin (32.87%), cardiac glycosides, and high carotenoids (672 mg/100g in leaves), which collectively exert antioxidant, anti-inflammatory, and cytotoxic effects via free radical scavenging and cell-protective mechanisms. Leaf extracts demonstrate 61.8% DPPH free radical inhibition in vitro, and root tissues express exceptionally high antioxidant enzyme concentrations — catalase at 6,250 µg/g and peroxidase at 4,310 µg/g — suggesting significant oxidative stress modulation potential, though no human clinical trials have confirmed these effects.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordCalotropis procera benefits
Calotropis procera — botanical close-up
Health Benefits
**Antioxidant Activity**: Leaf extracts achieve 61
8% DPPH radical inhibition, driven by high phenolic content and carotenoids (672 mg/100g); root tissues express catalase at 6,250 µg/g and superoxide dismutase at 892 µg/g, indicating robust enzymatic antioxidant capacity.
**Anti-Inflammatory Effects**
Betulin (58% of ethanolic extract) and α-amyrin (32.87%) are established triterpenoids that suppress pro-inflammatory pathways in preclinical models; traditional use for wound healing and swelling in Sahel communities aligns with these phytochemical findings.
**Anticancer Potential**
Betulin has demonstrated protection of HepG2 hepatocellular carcinoma cells and cytotoxic activity in vitro; α-amyrin similarly exhibits anticancer actions in cell-based studies, though no human trial data exist for this species specifically.
**Antimicrobial Properties**
Tannins, saponins, alkaloids, and flavonoids concentrated in aqueous and ethanolic extracts inhibit bacterial and microbial growth in laboratory assays; traditional applications for skin infections and wound management across West African communities reflect this bioactivity.
**Anti-Hyperglycemic Activity**
Animal and in vitro models show anti-glycemic effects attributed to phenolic compounds and flavonoids (up to 2.803 mg/100g in leaves) that may modulate glucose metabolism; this provides a pharmacological basis for traditional use in managing metabolic complaints.
**Proteolytic and Wound-Healing Activity**
Latex from Calotropis procera contains proteolytic enzymes that break down protein substrates, historically exploited for wound debridement and skin ailment treatment in traditional Sahelian medicine.
**Respiratory Support**
Traditional use in the Sahel targets bronchial and respiratory conditions, with alkaloids, terpenes, and latex bioactives hypothesized to reduce airway inflammation and microbial load, though direct clinical respiratory outcome data remain unavailable.
Origin & History
Natural habitat
Calotropis procera, commonly called the giant milkweed or sodom apple, is native to the arid and semi-arid regions of Africa, the Middle East, and South Asia, thriving across the Sahel belt from Senegal to Sudan and extending into the Indian subcontinent. It grows in sandy, degraded, and disturbed soils under intense heat and low rainfall, making it one of the most resilient shrubs of dryland ecosystems. Traditionally it is not cultivated but harvested wild, with the entire plant — root, latex, bark, leaves, and flowers — used medicinally by pastoralist and farming communities across the Sahel.
“Calotropis procera has been employed for centuries across the Sahel, West Africa, the Horn of Africa, and the Indian subcontinent as a multipurpose medicinal plant in Ayurvedic, Unani, and indigenous African healing traditions. In Sahelian communities, the latex is applied to skin lesions, snake bites, and parasitic infections, while leaf decoctions are administered for fever, bronchitis, and diarrhea; the plant is sometimes called 'the pharmacy of the poor' because of its accessibility in resource-limited dryland environments. In Ayurvedic medicine, the plant is known as 'Arka' and is listed in classical texts including the Charaka Samhita for treatment of skin diseases, respiratory disorders, and inflammatory conditions, typically prepared as medicated oils or ash-based formulations. Its cultural prominence extends to symbolic uses in Hindu rituals and as a boundary plant in pastoral communities, underscoring its deep integration into both material and spiritual dimensions of the societies that cultivated knowledge of its properties.”Traditional Medicine
Scientific Research
The evidence base for Calotropis procera consists entirely of phytochemical characterization, in vitro bioassays, and limited animal model studies, with no published randomized controlled trials or structured human clinical trials identified in the available literature. GC-MS studies have quantified bioactive compound profiles with statistical significance (p≤0.05) in antioxidant enzyme assays using sample sizes of approximately n=30, providing reproducible phytochemical benchmarks. Antioxidant, antimicrobial, anti-inflammatory, and cytotoxic properties have been demonstrated in cell-based and animal models, but effect sizes from human populations and pharmacokinetic data — including bioavailability, absorption rates, and therapeutic plasma concentrations — have not been established. The overall evidence quality is preclinical and preliminary; extrapolation to human supplementation or therapeutic use is not scientifically supported at this time.
Preparation & Dosage
Traditional preparation
**Aqueous Leaf Extract (Traditional)**
Prepared by boiling fresh or dried leaves in water; used topically or orally in folk medicine but no standardized dose established.
**Ethanolic Extract (Laboratory/Research Grade)**
Solvent extraction yields highest betulin (58%) and α-amyrin (32.87%) concentrations; no commercial supplement dose defined.
**DCM (Dichloromethane) Extract**
Enriches methyl eugenol (38.45%) and stigmasta-7,16-dien-3-ol (40.78%); used in phytochemical research, not available as a consumer product.
**Latex (Traditional Topical Use)**
Applied directly to skin wounds and lesions for proteolytic debridement; internal use is hazardous due to cardiac glycoside content.
**Dried Leaf Powder**
Used in traditional Sahel preparations; no validated therapeutic dose range from clinical trials.
**Standardization**
No commercial standardization to specific marker compounds (e.g., betulin percentage) has been established or validated.
**Dosage Guidance**
No safe or effective human dose has been determined; self-supplementation is not recommended pending clinical safety and efficacy studies.
Nutritional Profile
Calotropis procera is not a food ingredient but its plant parts contain measurable phytochemical concentrations relevant to biological activity: leaves contain total carotenoids at approximately 672 mg/100g dry weight (a notably high value suggesting significant provitamin A content), flavonoids at 2.803 mg/100g, and high phenolic compounds that correlate with antioxidant activity. The root tissues express antioxidant enzymes at high concentrations — superoxide dismutase 892 µg/g, catalase 6,250 µg/g, and peroxidase 4,310 µg/g — reflecting the plant's own oxidative stress management machinery. Ethanolic extracts are dominated by the triterpenoids betulin (58%) and α-amyrin (32.87%), while DCM extracts concentrate methyl eugenol (38.45%) and sterol stigmasta-7,16-dien-3-ol (40.78%); squalene (0.99%) and hexadecanoic acid methyl ester (1.47%) are minor components. Heavy metal content in aqueous leaf extracts is very low (e.g., Pb at 0.00005%), and the plant is not consumed as a food source due to toxicity concerns from cardiac glycosides and latex irritants.
How It Works
Mechanism of Action
Betulin and α-amyrin, the dominant triterpenoids in ethanolic extracts, exert anti-inflammatory effects by inhibiting NF-κB signaling and cyclooxygenase enzyme activity in preclinical models, reducing downstream production of pro-inflammatory cytokines. The high phenolic and flavonoid content in leaves drives direct free radical scavenging via hydrogen atom transfer and electron donation, contributing to the observed 61.8% DPPH inhibition, while simultaneously upregulating endogenous antioxidant enzymes including catalase and peroxidase in root tissues. Cardiac glycosides and cardenolides in the latex inhibit Na⁺/K⁺-ATPase pumps, which underlies both their cytotoxic potential against cancer cell lines and their toxicological risk at elevated doses. Methyl eugenol (38.45% of DCM extract) and stigmasta-7,16-dien-3-ol (40.78%) contribute antimicrobial and membrane-disrupting activity, while the high carotenoid content (672 mg/100g) may modulate immune cell signaling through vitamin A precursor pathways, although specific intracellular signaling cascades have not been fully characterized for this species.
Clinical Evidence
No human clinical trials investigating Calotropis procera as a supplement or therapeutic agent have been published, meaning there are no effect sizes, confidence intervals, or clinical outcome data from controlled human studies to summarize. Available biological data derive from in vitro assays and animal studies demonstrating antioxidant (61.8% DPPH inhibition), antimicrobial, anti-inflammatory, and cytotoxic activities, which establish pharmacological plausibility but not clinical efficacy or safety in humans. Traditional use across Sahelian Africa over many generations provides ethnobotanical validation for respiratory, dermatological, and antimicrobial applications, but this does not substitute for controlled clinical evidence. Confidence in any specific therapeutic claim remains low; the ingredient is best classified as a candidate for future translational research rather than a clinically validated supplement.
Safety & Interactions
Calotropis procera latex contains cardiac glycosides (cardenolides) that inhibit Na⁺/K⁺-ATPase at elevated doses, posing a risk of cardiac arrhythmia, and the latex is a direct irritant producing nitrogen dioxide (NO₂), sulfur dioxide (SO₂), and particulate matter upon contact or inhalation, making occupational or topical exposure without precaution hazardous. Internal consumption of latex or unprocessed plant material is contraindicated without controlled extraction and dose determination; there are no established maximum safe doses for any plant part in humans. Potential interactions with cardiac glycoside-sensitive medications (e.g., digoxin, antiarrhythmics) and anticoagulants are plausible given the plant's pharmacological profile, though no formal drug interaction studies have been conducted. Calotropis procera is not recommended during pregnancy or lactation due to the absence of safety data, traditional reports of abortifacient activity attributed to this plant in some ethnobotanical records, and the inherent toxicity of its latex alkaloids and glycosides.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Calotropis proceraGiant milkweedSodom appleArka (Ayurvedic)Mudar plantApple of SodomRoostertree
Frequently Asked Questions
What is Calotropis procera used for traditionally?
Calotropis procera has been used traditionally across the Sahel, West Africa, and South Asia for respiratory ailments such as bronchitis, skin conditions including wounds and lesions, fever, diarrhea, and anti-inflammatory purposes. The latex is applied topically for its proteolytic wound-debridement activity, while leaf and root decoctions are prepared as oral remedies. In Ayurvedic medicine it is classified as 'Arka' and prescribed for skin diseases and inflammatory disorders.
Is Calotropis procera safe to consume?
Calotropis procera is not considered safe for unsupervised oral consumption because its latex and plant tissues contain cardiac glycosides (cardenolides) that inhibit the Na⁺/K⁺-ATPase pump and can cause cardiac arrhythmia at elevated doses. The latex is also a direct mucosal and skin irritant due to NO₂ and SO₂ production. No safe human dosage has been established through clinical trials, and self-supplementation is strongly discouraged.
What are the main bioactive compounds in Calotropis procera?
GC-MS analysis identifies betulin (58% of ethanolic extract) and α-amyrin (32.87%) as the dominant triterpenoids, alongside methyl eugenol (38.45%) and stigmasta-7,16-dien-3-ol (40.78%) in DCM extracts. The leaves are rich in carotenoids (672 mg/100g) and flavonoids (2.803 mg/100g), while the latex concentrates cardiac glycosides, terpenes, and proteolytic enzymes. Roots express high antioxidant enzyme activity including catalase at 6,250 µg/g.
Does Calotropis procera have antioxidant properties?
Yes, leaf extracts of Calotropis procera demonstrate 61.8% DPPH free radical inhibition in vitro, attributed to high phenolic compound and carotenoid content. Root tissues contain exceptionally high concentrations of antioxidant enzymes — catalase at 6,250 µg/g and peroxidase at 4,310 µg/g — indicating strong enzymatic oxidative stress management. These findings are from preclinical laboratory studies; equivalent antioxidant effects in living humans have not been confirmed.
Are there any clinical trials on Calotropis procera?
No human randomized controlled trials or structured clinical trials investigating Calotropis procera for any health outcome have been published in the available scientific literature. Existing evidence is limited to in vitro phytochemical assays, antioxidant activity measurements, and animal model studies demonstrating anti-inflammatory, antimicrobial, and cytotoxic properties. The ingredient remains in the preclinical research phase, and claims about human therapeutic benefit cannot be substantiated by controlled clinical data at this time.
What is the difference between Calotropis procera leaf extract and root extract?
Calotropis procera leaves and roots have distinct antioxidant profiles: leaf extracts are rich in phenolic compounds and carotenoids (672 mg/100g), achieving 61.8% DPPH radical inhibition, while root tissues express high levels of enzymatic antioxidants like catalase (6,250 µg/g) and superoxide dismutase (892 µg/g). Root extracts may be more beneficial for supporting endogenous antioxidant enzyme systems, whereas leaf extracts provide direct free radical-scavenging activity from phytochemicals. The choice between them depends on whether you seek enzymatic or non-enzymatic antioxidant support.
Which form of Calotropis procera is most effective—extract, powder, or whole herb?
Standardized ethanolic extracts of Calotropis procera are likely most effective, as they concentrate bioactive triterpenoids like betulin (58% of extract) and α-amyrin (32.87%) while removing inactive plant material. Whole herb powders contain these compounds but in lower concentrations and with variable potency depending on plant part and growing conditions. Extract forms offer superior bioavailability and consistency, making them the preferred choice for targeted anti-inflammatory and antioxidant benefits in supplement formulations.
Is Calotropis procera more beneficial for acute inflammation or chronic oxidative stress?
Calotropis procera appears particularly suited for addressing chronic oxidative stress due to its dual antioxidant mechanism: high phenolic content in leaves provides acute free radical scavenging, while root tissues offer sustained enzymatic antioxidant support through catalase and superoxide dismutase expression. The established anti-inflammatory triterpenoids (betulin and α-amyrin) suggest benefit for both acute and chronic inflammation, but the robust enzymatic antioxidant capacity makes it especially valuable for long-term cellular protection against oxidative damage. Regular use may be more appropriate for chronic conditions than acute inflammatory episodes.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w calotropis-procera-calotropis-procera curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
